This inventor holds 2 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ikoma, JP (2021)
- Nara, JP (2022)
Company Filing History:
Years Active: 2021-2022
Title: Toyomi Fujisawa: Innovator in Pharmaceutical Applications
Introduction
Toyomi Fujisawa is a notable inventor based in Nara, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing innovative solutions that enhance the effectiveness of pharmaceutical compositions.
Latest Patents
Fujisawa's latest patents include an "Antiseptic agent comprising meglumine or salt thereof." This invention addresses the need for a novel application of meglumine or its salts, providing an antiseptic agent that does not contain benzalkonium chloride and can be placed in a reusable container. Additionally, he has developed a "Sustained-release pharmaceutical composition," which relates to an ophthalmic depot preparation that includes specific ratios of benzyl benzoate and polyethylene glycol, ensuring a high concentration of active ingredients.
Career Highlights
Throughout his career, Fujisawa has worked with prominent companies such as Santen Pharmaceutical Co., Ltd. and Singapore Health Services Pte Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations.
Collaborations
Fujisawa has collaborated with notable colleagues, including Shinya Umezaki and Kazuhito Yamada. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Toyomi Fujisawa's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
